1. Home
  2. BGLC vs SYRA Comparison

BGLC vs SYRA Comparison

Compare BGLC & SYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • SYRA
  • Stock Information
  • Founded
  • BGLC N/A
  • SYRA 2020
  • Country
  • BGLC Malaysia
  • SYRA United States
  • Employees
  • BGLC 30
  • SYRA N/A
  • Industry
  • BGLC Medical Specialities
  • SYRA Other Specialty Stores
  • Sector
  • BGLC Health Care
  • SYRA Industrials
  • Exchange
  • BGLC Nasdaq
  • SYRA Nasdaq
  • Market Cap
  • BGLC 9.2M
  • SYRA 8.5M
  • IPO Year
  • BGLC N/A
  • SYRA 2023
  • Fundamental
  • Price
  • BGLC $0.49
  • SYRA $1.33
  • Analyst Decision
  • BGLC
  • SYRA
  • Analyst Count
  • BGLC 0
  • SYRA 0
  • Target Price
  • BGLC N/A
  • SYRA N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • SYRA 50.9K
  • Earning Date
  • BGLC N/A
  • SYRA 08-13-2024
  • Dividend Yield
  • BGLC N/A
  • SYRA N/A
  • EPS Growth
  • BGLC N/A
  • SYRA N/A
  • EPS
  • BGLC N/A
  • SYRA N/A
  • Revenue
  • BGLC N/A
  • SYRA $6,079,133.00
  • Revenue This Year
  • BGLC N/A
  • SYRA $70.86
  • Revenue Next Year
  • BGLC N/A
  • SYRA N/A
  • P/E Ratio
  • BGLC N/A
  • SYRA N/A
  • Revenue Growth
  • BGLC N/A
  • SYRA 3.73
  • 52 Week Low
  • BGLC N/A
  • SYRA $0.81
  • 52 Week High
  • BGLC N/A
  • SYRA $8.37
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 47.35
  • SYRA 45.79
  • Support Level
  • BGLC $0.46
  • SYRA $1.30
  • Resistance Level
  • BGLC $0.49
  • SYRA $1.37
  • Average True Range (ATR)
  • BGLC 0.02
  • SYRA 0.07
  • MACD
  • BGLC 0.00
  • SYRA -0.00
  • Stochastic Oscillator
  • BGLC 55.69
  • SYRA 41.18

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About SYRA Syra Health Corp.

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

Share on Social Networks: